Navigation Links
Cell Therapeutics, Inc. (CTI) to Present at BioCentury's NewsMakers in the Biotech Industry Conference
Date:9/9/2009

SEATTLE, Sept. 10 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) management will present at BioCentury's NewsMakers in the Biotech Industry conference on Wednesday, September 16, 2009, at 10:30 AM Eastern.

The conference will be held September 16, 2009, at the Millennium Broadway Hotel in New York. The conference will be webcast live with slides and available for replay after the presentation. The webcast can be accessed at www.celltherapeutics.com.

              BioCentury's NewsMakers in Biotech Industry Conference
                 CTI Presentation: Wednesday, September 16, 2009
          10:30 a.m. Eastern /7:30 a.m. Pacific /6:30 p.m. Central European
              Audio webcast with slides at www.celltherapeutics.com

    Media Contact:
    Dan Eramian
    T: 206.272.4343
    C: 206.854.1200
    F: 206.272.4434
    E: media@ctiseattle.com
    www.celltherapeutics.com/press_room

    Investors Contact:
    Ed Bell
    T: 206.272.4345
    Lindsey Jesch Logan
    T: 206.272.4347
    F: 206.272.4434
    E: invest@ctiseattle.com
    www.celltherapeutics.com/investors


'/>"/>
SOURCE Cell Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Oxygen Biotherapeutics, Inc. Seeks Shareholder Approval for Reverse Stock Split
2. Cell Therapeutics, Inc. (CTI) to Present at Rodman & Renshaw Healthcare Conference
3. Oxygen Biotherapeutics, Inc. to Present at Investment Conferences in New York and Zurich
4. Cell Therapeutics, Inc. Announces Closing of Registered Offering of $30 Million of Preferred Stock and Warrants
5. Cell Therapeutics, Inc. Announces Institutional Investor Purchases $30 Million of Preferred Stock and Warrants
6. Oxygen Biotherapeutics, Inc. Files 10-K for Fiscal Year Ended April 30, 2009
7. Nile Therapeutics, Inc. Announces Dosing of First Patient in Phase 2 Study of CD-NP for the Treatment of Acute Heart Failure
8. Cell Therapeutics, Inc. Announces Exercise of Overallotment
9. Cell Therapeutics, Inc. Announces Pricing of Public Offering of Common Stock and Warrants
10. Nile Therapeutics, Inc. Completes $3.4 Million Private Placement
11. Oxygen Biotherapeutics, Inc. Announces Closing of Private Placement Financing Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... Portal Solutions , a technology consulting firm that designs ... and SharePoint platforms , today announces its inclusion in Washington ... the region’s fastest-growing mid-sized companies based on a combined three-year ... recognized a second year in a row by SmartCEO is ...
(Date:1/22/2015)... 2015 Shimadzu Scientific Instruments today ... UV-visible spectrophotometer. Offering wavelength scanning from 190 to ... for applications in a variety of industries, including ... user-friendly UV-1280 enables intuitive operation, while the enhanced ...
(Date:1/22/2015)... NH (PRWEB) January 22, 2015 GEA ... a table top laboratory homogenizer, the PandaPLUS 2000, which ... nanodispersions, nanoemulsions , and cell disruption . This ... dairy products, fruit juices, liquid food, food additives and ...
(Date:1/22/2015)... 21, 2015 Cambridge Semantics, the leading provider ... announced that 2014 was a record-breaking year across the board ... the Anzo Smart Data Platform and our Smart Data solutions, ... from diverse data which led to record growth for the ...
Breaking Biology Technology:Washington SmartCEO Announces Portal Solutions as 2015 Future 50 Award Winner Second Year in a Row 2Washington SmartCEO Announces Portal Solutions as 2015 Future 50 Award Winner Second Year in a Row 3Shimadzu’s New Monitored Single-Beam UV-Vis Spectrophotometer Offers Comprehensive Measurement Options in a Compact Body 2GEA Niro Soavi Announces the PandaPLUS 2000 Homogenizer for Processing New Applications for Nanoemulsions and Cell Disruption 2Cambridge Semantics Announces Record Results for 2014 2
... Introduction , ... algorithms for monitoring GeneChip ® expression data. These ... designed to accommodate the typical distribution of data found ... statistical techniques and are optimized to accommodate advancements in ...
... Chromatography and Mass Spectrometry Application Report , ... serum Acepromazine , Gargi Choudhary, Thermo ... Wayne Skinner and Scott Stanley, University of California, Davis ... Acepromazine is widely used as a sedative in horses. ...
... Mass Spectrometry Application Note , Kevin ... Thermo Electron Corporation, Somerset, NJ, USA , ... Acrylamide has been identified as a potential ... industrial chemical, but acrylamide was recently discovered to be present at significant ...
Cached Biology Technology:New statistical algorithms for Monitoring Gene Expression on GeneChip® Probe Arrays 2New statistical algorithms for Monitoring Gene Expression on GeneChip® Probe Arrays 3New statistical algorithms for Monitoring Gene Expression on GeneChip® Probe Arrays 4New statistical algorithms for Monitoring Gene Expression on GeneChip® Probe Arrays 5New statistical algorithms for Monitoring Gene Expression on GeneChip® Probe Arrays 6Determination of Acepromazine and its Major Metabolite in Equine Serum by LC-MS/MS using the Finnigan LCQ Deca XP Plus Ion Trap Mass Spectrometer 2Determination of Acepromazine and its Major Metabolite in Equine Serum by LC-MS/MS using the Finnigan LCQ Deca XP Plus Ion Trap Mass Spectrometer 3Determination of Acepromazine and its Major Metabolite in Equine Serum by LC-MS/MS using the Finnigan LCQ Deca XP Plus Ion Trap Mass Spectrometer 4Quantitation of Acrylamide in Food Samples on the Finnigan TSQ Quantum Discovery by LC/APCI-MS/MS 2Quantitation of Acrylamide in Food Samples on the Finnigan TSQ Quantum Discovery by LC/APCI-MS/MS 3Quantitation of Acrylamide in Food Samples on the Finnigan TSQ Quantum Discovery by LC/APCI-MS/MS 4Quantitation of Acrylamide in Food Samples on the Finnigan TSQ Quantum Discovery by LC/APCI-MS/MS 5Quantitation of Acrylamide in Food Samples on the Finnigan TSQ Quantum Discovery by LC/APCI-MS/MS 6
(Date:1/22/2015)... Inc. , a market leader of iris-based identity authentication solutions, ... the new role of Senior Vice President of Mobile and ... platforms and wearable solutions for EyeLock,s technologies. Gerber brings more ... industry to his role at EyeLock, with expertise in human ...
(Date:12/24/2014)... YORK , Dec. 23, 2014  Since its launch in December ... people to eliminate the pain of trying to remember their ... own biometrics fused to their smartphones. To assist people who ... , the company that created 1U and focuses on redefining ...
(Date:12/22/2014)... 22, 2014 Research and Markets ( ... "The Global Watermarking and Fingerprinting Markets" ... http://photos.prnewswire.com/prnh/20130307/600769 This insight provides ... and fingerprinting markets. Watermarking aims to control and ...
Breaking Biology News(10 mins):EyeLock Names Steve Gerber as Senior Vice President of Mobile and Wearables 21U Offers Best Solution to the Username / Password Dilemma: For FREE! 21U Offers Best Solution to the Username / Password Dilemma: For FREE! 3The Global Watermarking and Fingerprinting Markets 2
... American Society for Microbiology (ASM) sanofi-aventis U.S. Award ... WWAMI Regional Center of Excellence for Biodefense and ... an unrestricted grant from sanofi-aventis U.S., this award ... his professional life, Dr. Stamm has worked with ...
... of biosolids (treated municipal sewage sludge) is a common ... nutrients and organic matter. However, the presence of detectable ... farmland application may result in accumulation of dioxins in ... chain because several congeners of dioxins have extremely high ...
... Spanish . Cancer is a disease characterised ... give higher proliferative capacity to cancer cells, but they ... research group led by Dr. Jos Carlos Fernndez-Checa in ... (IIBB-CSIC), a centre linked to the Institut d,Investigacions Biomdiques ...
Cached Biology News:Dioxin risk in soil and plant tissues after long-term biosolids application 2Mitochondrial cholesterol makes response to chemotherapy difficult in hepatic cancer 2
Donor Horse Serum US Origin...
jub, ajuba homolog (Xenopus laevis)...
Size & Applications: 100 ul (2 mM). Recommend to use at 1000X dilutions for cell culture (e.g. Add 1 ul to 1 ml of culture medium.) Storage Temp.: -20C Shelf Life: 6-12 month...
NM522 contains an F episome, which is required for production of ssDNA and for blue/white color selection. To maintain the F, NM522 should be grown on minimal (M-9) medium....
Biology Products: